Founded in 2009, JYMed is a leading peptide CRDMO service provider and generic API manufacturer in China specializing in the custom synthesis, process development, clinical supply and commercialization of peptide substances. The company employs approximately 600+ FTEs, with a core management team composed of experts with over 20 years of experience in peptide technology. JYMed operates one R&D center and two major multi-purpose production facilities, with multi-ton scale peptide manufacturing capacity.

ABOUT
JYMED

JYMed is a US FDA-inspected peptide manufacturer specializing in cosmetic peptides, peptide APIs, and custom peptides. Our featured products include Semaglutide, Liraglutide, Tirzepatide, Oxytocin, GHK, GHK-Cu, Acetyl Hexapeptide-8, and more. To learn more, please contact us at:

Email: jymed@jymedtech.com

news and information